Pharmaceutical preparation with RNA as hemostasis cofactor

Details for Australian Patent Application No. 2003231661 (hide)

Owner CSL Behring GmbH

Inventors Nakazawa, Fumie; Roemisch, Juergen; Kannemeier, Christian; Preissner, Klaus

Agent Watermark

Pub. Number AU-B-2003231661

Priority 102 36 038.3 06.08.02 DE; 103 09 368.0 03.03.03 DE

Filing date 6 August 2003

Wipo publication date 26 February 2004

Acceptance publication date 27 May 2010

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12Q 1/56 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/86 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

Event Publications

21 August 2003 Complete Application Filed

  Priority application(s): 102 36 038.3 06.08.02 DE; 103 09 368.0 03.03.03 DE

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003231661

17 March 2005 Change of Name(s) of Applicant(s), Section 104

  Aventis Behring GmbH The name of the applicant has been changed to ZLB Behring GmbH

23 August 2007 Change of Name(s) of Applicant(s), Section 104

  ZLB Behring GmbH The name of the applicant has been changed to CSL Behring GmbH

27 May 2010 Application Accepted

  Published as AU-B-2003231661

23 September 2010 Standard Patent Sealed

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003231662-Portable drum dosing system

2003231660-Compositions and methods for targeted delivery of factors